Expression of pituitary tumor-transforming gene in endometrial cancer as a prognostic marker

International Journal of Gynecological Cancer

Volumn 18, Issue 6, 2008, Pages 1352-1359

  Kim, J W ^a   Song, J Y ^a   Lee, J M ^a   Lee, J K ^b   Lee, N W ^c   Yeom, B W ^a   Lee, K W ^a  

^a College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University   (South Korea)

Author keywords

Endometrial cancer; FGF 2; PTTG

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE; PITUITARY TUMOR TRANSFORMING GENE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 55949134937     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01168.x     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007 57 : 43 66.
2. Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1997 11 : 433 41.
3. Zhang X, Horwitz GA, Prezant TR et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1999 13 : 156 66.
4. Heaney AP, Nelson V, Fernando M, Horwitz G. Transforming events in thyroid tumorigenesis and their association with follicular lesions. J Clin Endocrinol Metab 2001 86 : 5025 32.
5. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 2000 355 : 716 9.
6. Puri R, Tousson A, Chen L, Kakar SS. Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. Cancer Lett 2001 163 : 131 9.
7. Saez C, Pereda T, Borrero JJ et al. Expression of hpttg proto-oncogene in lymphoid neoplasias. Oncogene 2002 21 : 8173 7.
8. Solbach C, Roller M, Fellbaum C, Nicoletti M, Kaufmann M. PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence. Breast 2004 13 : 80 1.
9. Yu R, Melmed S. Oncogene activation in pituitary tumors. Brain Pathol 2001 11 : 328 41.
10. Hamid T, Kakar SS. PTTG/securin activates expression of p53 and modulates its function. Mol Cancer 2004 3 : 18.
11. Fujimoto J, Hori M, Ichigo S, Tamaya T. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers. Invasion Metastasis 1995 15 : 203 10.
12. Fujimoto J, Hori M, Ichigo S, Tamaya T. Expressions of the fibroblast growth factor family (FGF-1, -2 and -4) mRNA in endometrial cancers. Tumour Biol 1996 17 : 226 33.
13. Fujimoto J, Ichigo S, Hirose R, Sakaguchi H, Tamaya T. Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers. Cancer Lett 1998 134 : 15 22.
14. Fujimoto J, Ichigo S, Hori M, Hirose R, Sakaguchi H, Tamaya T. Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers. Cancer Lett 1997 111 : 21 6.
15. Fujimoto J, Ichigo S, Sakaguchi H, Hirose R, Tamaya T. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers. Cancer Lett 1998 130 : 115 20.
16. Fujimoto J, Toyoki H, Jahan I et al. Sex steroid-dependent angiogenesis in uterine endometrial cancers. J Steroid Biochem Mol Biol 2005 93 : 161 5.
17. Bai X, Mi R. Expression of basic fibroblastic growth factor and microvessel density in endometrial carcinoma. Zhonghua Fu Chan Ke Za Zhi 2000 35 : 348 51.
18. Bai X, Mi R. Expression of VEGF, bFGF and ER in endometrial carcinoma. Zhonghua Zhong Liu Za Zhi 2001 23 : 211 3.
19. Wang YK, Cui N, Li J, Luo B. Expression of pituitary tumor-transforming gene in endometrial carcinoma. Zhonghua Fu Chan Ke Za Zhi 2004 39 : 538 42.
20. Chambers JT, Carcangiu ML, Voynick IM, Schwartz PE. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: correlation between biochemical and immunohistochemical methods and survival. Am J Clin Pathol 1990 94 : 255 60.
21. Geisinger KR, Marshall RB, Kute TE, Homesley HD. Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium. Cancer 1986 58 : 1506 17.
22. Gorchev G, Milkov V. Estrogen and progesterone receptors as prognostic markers in endometrial carcinoma. Akush Ginekol (Sofiia) 1992 31 : 32 3.
23. Fujimoto J, Hori M, Ichigo S, Hirose R, Tamaya T. Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells. Gen Pharmacol 1997 28 : 215 9.
24. Ishikawa H, Heaney AP, Yu R, Horwitz GA, Melmed S. Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab 2001 86 : 867 74.
25. McCabe CJ, Khaira JS, Boelaert K et al. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol (Oxf) 2003 58 : 141 50.
26. Ogbagabriel S, Fernando M, Waldman FM, Bose S, Heaney AP. Securin is overexpressed in breast cancer. Mod Pathol 2005 18 : 985 90.
27. Robbins J, Dilworth SM, Laskey RA, Dingwall C. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 1991 64 : 615 23.
28. Pemberton LF, Blobel G, Rosenblum JS. Transport routes through the nuclear pore complex. Curr Opin Cell Biol 1998 10 : 392 9.
29. Chien W, Pei L. A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. J Biol Chem 2000 275 : 19422 7.
30. Dominguez A, Ramos-Morales F, Romero F et al. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 1998 17 : 2187 93.
31. Boelaert K, Yu R, Tannahill LA et al. PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro. J Mol Endocrinol 2004 33 : 663 77.
32. Pei L. Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function. J Biol Chem 2000 275 : 31191 8.
33. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999 5 : 1317 21.
34. Heaney AP, Fernando M, Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 2002 109 : 277 83.
35. Aupperle H, Ozgen SHA, Schoon D, Hoppen HO, Sieme H, Tannapfel A. Cyclical endometrial steroid hormone receptor expression and proliferation intensity in the mare. Equine Vet J 2000 32 : 228 32.